Theranostic systems that integrate diagnostic monitoring and therapeutic intervention within unified platforms represent a transformative approach for precision medicine. While wearable microneedle (MN)-based devices offer an ideal form factor for such systems, their development has been constrained by limitations in molecular recognition specificity, intelligent decision-making capability, and controlled drug release precision. Nucleic acid technology emerges as a comprehensive solution to these challenges, leveraging its inherent programmability and molecular recognition versatility to address all three core theranostic components. This review systematically examines recent advances in nucleic acid-based strategies for intelligent theranostics, focusing on three fundamental modules: (1) in situ monitoring systems employing aptamers, CRISPR mechanisms, and molecular pendulums; (2) decision-making units utilizing threshold-controlled circuits and feedback-regulation networks; and (3) stimulus-responsive drug delivery units featuring programmable release mechanisms for various therapeutic agents. We further highlight integrated nucleic acid-MN platforms that demonstrate closed-loop operation, continuously sensing biomarker fluctuations and triggering precise therapeutic responses. Finally, we discuss prevailing challenges in stability, specificity, and clinical translation, while outlining future research directions aimed at advancing autonomous molecular decision systems for personalized medicine applications. This comprehensive analysis provides foundational insights for developing next-generation intelligent theranostic platforms capable of adaptive, precision healthcare delivery.
{"title":"Nucleic Acid-Microneedle-Based Wearable Theranostic Platforms for Precision Medicine: Advances and Prospects","authors":"Lilan Xu, Zhilong Dai, Jiayan Wu, Xinming Luo, Wanting Huang, Jinfeng Lin, Xiaobing Huang, Guanyu Chen, Jinghua Chen","doi":"10.1002/anse.202500223","DOIUrl":"https://doi.org/10.1002/anse.202500223","url":null,"abstract":"<p>Theranostic systems that integrate diagnostic monitoring and therapeutic intervention within unified platforms represent a transformative approach for precision medicine. While wearable microneedle (MN)-based devices offer an ideal form factor for such systems, their development has been constrained by limitations in molecular recognition specificity, intelligent decision-making capability, and controlled drug release precision. Nucleic acid technology emerges as a comprehensive solution to these challenges, leveraging its inherent programmability and molecular recognition versatility to address all three core theranostic components. This review systematically examines recent advances in nucleic acid-based strategies for intelligent theranostics, focusing on three fundamental modules: (1) in situ monitoring systems employing aptamers, CRISPR mechanisms, and molecular pendulums; (2) decision-making units utilizing threshold-controlled circuits and feedback-regulation networks; and (3) stimulus-responsive drug delivery units featuring programmable release mechanisms for various therapeutic agents. We further highlight integrated nucleic acid-MN platforms that demonstrate closed-loop operation, continuously sensing biomarker fluctuations and triggering precise therapeutic responses. Finally, we discuss prevailing challenges in stability, specificity, and clinical translation, while outlining future research directions aimed at advancing autonomous molecular decision systems for personalized medicine applications. This comprehensive analysis provides foundational insights for developing next-generation intelligent theranostic platforms capable of adaptive, precision healthcare delivery.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"6 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146130147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shivani Achar, Ramesh S. Bhat, Badekai Ramachandra Bhat, Prashanth W. Menezes
The present study reveals the fabrication of transition metal oxides based nanohybrids for the sensitive electroanalytical differentiation of dihydroxybenzene isomers (DHBIs). The Ag-MnCuO nanohybrid is prepared through the facile combustion method and further functionalized by poly-arginine (PA). The prepared nanohybrid is validated through X-ray diffraction, energy-dispersive X-ray analysis, field-emission scanning electron microscopy, and Raman spectroscopy. The glassy carbon electrode is modified with Ag-MnCuO nanohybrid and forms the PA-rGO-Ag-MnCuO, which exhibits superior electrocatalytic activity for the identification of catechol (CE), hydroquinone (HR), and resorcinol (RO). The prepared nanohybrid on the electrode exhibits higher electrochemical properties with a limit of detection for the detection of CE (0.107 μM), HR (0.069 μM), and RO (0.094 μM). The efficiency of the prepared electrode is validated by a remarkable recovery percentage in the market source of DHBI samples. The proposed electrode demonstrates high stability, selectivity, repeatability, reproducibility, and synchronized detection of DHBIs, highlighting its potential for practical use in photochemical and environmental applications.
{"title":"Highly Selective Detection of Dihydroxybenzene Isomers via L-Arginine/Ag-MnCuO Nanohybrid Modified Glassy Carbon Electrode","authors":"Shivani Achar, Ramesh S. Bhat, Badekai Ramachandra Bhat, Prashanth W. Menezes","doi":"10.1002/anse.202500168","DOIUrl":"https://doi.org/10.1002/anse.202500168","url":null,"abstract":"<p>The present study reveals the fabrication of transition metal oxides based nanohybrids for the sensitive electroanalytical differentiation of dihydroxybenzene isomers (DHBIs). The Ag-MnCuO nanohybrid is prepared through the facile combustion method and further functionalized by poly-arginine (PA). The prepared nanohybrid is validated through X-ray diffraction, energy-dispersive X-ray analysis, field-emission scanning electron microscopy, and Raman spectroscopy. The glassy carbon electrode is modified with Ag-MnCuO nanohybrid and forms the PA-rGO-Ag-MnCuO, which exhibits superior electrocatalytic activity for the identification of catechol (CE), hydroquinone (HR), and resorcinol (RO). The prepared nanohybrid on the electrode exhibits higher electrochemical properties with a limit of detection for the detection of CE (0.107 μM), HR (0.069 μM), and RO (0.094 μM). The efficiency of the prepared electrode is validated by a remarkable recovery percentage in the market source of DHBI samples. The proposed electrode demonstrates high stability, selectivity, repeatability, reproducibility, and synchronized detection of DHBIs, highlighting its potential for practical use in photochemical and environmental applications.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"6 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A new sensing microtiter plate platform enables rapid, one-step, ratiometric fluorescence detection of H2O2 using Amplex Red in hydrogel membranes with Cy5-based reference nanoparticles. It offers 3-minute readouts and 10 times lower detection limit than commercial kits while minimizing preparation steps. With enzyme functionalization, the platform supports glucose and lactate detection, offering a simplified yet powerful alternative to multistep assays. More in the Research Article by Axel Duerkop and co-workers.